PCSK9 Inhibitors in Heart Transplant Patients: Safety, Efficacy, and Angiographic Correlates-Reference-Cited by-同舟云学术

PCSK9 Inhibitors in Heart Transplant Patients: Safety, Efficacy, and Angiographic Correlates

Published:2021-07 Issue:7 Volume:27 Page:812-815
ISSN:1071-9164
Container-title:Journal of Cardiac Failure
language:en
Short-container-title:Journal of Cardiac Failure

Author:

Sammour Yasser^ORCID,Dezorzi Christopher^ORCID,Austin Bethany A.^ORCID,Borkon A. Michael,Everley Mark P.,Fendler Timothy J.,Khumri Taiyeb M.,Lawhorn Stephanie L.^ORCID,Nassif Michael E.,Vodnala Deepthi,Magalski Anthony,Kao Andrew C.^ORCID,Sperry Brett W.^ORCID

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference8 articles.

1. The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients;Costanzo;J Heart Lung Transplant,2010

2. Cardiovascular outcomes of PCSK9 inhibitors: with special emphasis on its effect beyond LDL-cholesterol lowering;Bandyopadhyay;J Lipids,2018

3. Effect of access to prescribed PCSK9 inhibitors on cardiovascular outcomes;Myers;Circ Cardiovasc Outcomes,2019

4. Influence of donor transmitted and rapidly progressive coronary vascular disease on long term outcomes after heart transplantation: a contemporary intravascular ultrasound analysis;Sperry;J Card Fail,2021

5. Treatment of hypercholesterolaemia with PCSK9 inhibitors in patients after cardiac transplantation;Kuhl;PloS One,2019

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Use of Evolocumab in Familial Hyperlipidemia With Isolated Heart Transplant;JACC: Case Reports;2024-08

2. Prevention and Rehabilitation After Heart Transplantation: A Clinical Consensus Statement of the European Association of Preventive Cardiology, Heart Failure Association of the ESC, and the European Cardio Thoracic Transplant Association, a Section of ESOT;Transplant International;2024-06-19

3. Prevention and rehabilitation after heart transplantation: A clinical consensus statement of the European Association of Preventive Cardiology, Heart Failure Association of the ESC, and the European Cardio Thoracic Transplant Association, a section of ESOT;European Journal of Preventive Cardiology;2024-06-19

4. Prevention and rehabilitation after heart transplantation: A clinical consensus statement of the European Association of Preventive Cardiology, Heart Failure Association of the ESC, and the European Cardio Thoracic Transplant Association, a section of ESOT;EUR J HEART FAIL;2024

5. Effects of PCSK9 on thrombosis and haemostasis in a variety of metabolic states: Lipids and beyond (Review);International Journal of Molecular Medicine;2024-05-10